524 related articles for article (PubMed ID: 14529977)
1. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of resected subcentimeter lung cancer.
Sakurai H; Nakagawa K; Watanabe S; Asamura H
Ann Thorac Surg; 2015 May; 99(5):1731-8. PubMed ID: 25825199
[TBL] [Abstract][Full Text] [Related]
3. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
5. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
7. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
Matsuguma H; Nakahara R; Anraku M; Kondo T; Tsuura Y; Kamiyama Y; Mori K; Yokoi K
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1102-6. PubMed ID: 15145016
[TBL] [Abstract][Full Text] [Related]
8. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study.
Kodama K; Higashiyama M; Takami K; Oda K; Okami J; Maeda J; Koyama M; Nakayama T
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1068-74. PubMed ID: 18760618
[TBL] [Abstract][Full Text] [Related]
10. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
[TBL] [Abstract][Full Text] [Related]
11. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis.
Fukui T; Katayama T; Ito S; Abe T; Hatooka S; Mitsudomi T
Lung Cancer; 2009 Dec; 66(3):309-13. PubMed ID: 19344976
[TBL] [Abstract][Full Text] [Related]
13. Is limited resection appropriate for radiologically "solid" tumors in small lung cancers?
Hattori A; Suzuki K; Matsunaga T; Fukui M; Kitamura Y; Miyasaka Y; Tsushima Y; Takamochi K; Oh S
Ann Thorac Surg; 2012 Jul; 94(1):212-5. PubMed ID: 22560966
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.
Ohtsuka T; Watanabe K; Kaji M; Naruke T; Suemasu K
Eur J Cardiothorac Surg; 2006 Jul; 30(1):160-3. PubMed ID: 16723239
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
16. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
17. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
[TBL] [Abstract][Full Text] [Related]
18. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis in clinical stage IA peripheral lung cancer.
Wang L; Jiang W; Zhan C; Shi Y; Zhang Y; Lin Z; Yuan Y; Wang Q
Lung Cancer; 2015 Oct; 90(1):41-6. PubMed ID: 26212683
[TBL] [Abstract][Full Text] [Related]
20. [Surgical outcome for small-sized non-small-cell lung cancer].
Sato N; Kamata S; Niikawa H; Imai T
Kyobu Geka; 2012 Jan; 65(1):17-20. PubMed ID: 22314151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
